SAS Output

13-JUL-2020 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 449 11 574 35 426 67 408
ERLYTX 173 0 0 3 37 8 49
GI 283 3 157 12 146 14 85
GU 708 16 835 61 743 127 773
LEUK 156 5 261 9 110 16 97
LUNG 251 6 313 24 292 36 219
LYMPH 223 5 261 25 304 54 329
MELAN 195 1 52 10 122 23 140
MMYEL 179 4 209 19 231 32 195
OTHER 24 1 52 4 49 7 43
SXQOL 11 1 52 2 24 3 18
Total 2652 53 2766 204 2484 387 2356

13-JUL-2020 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 54 1 52 3 37 6 37
CCD 1234 15 783 59 718 106 645
GU 17 0 0 0 0 0 0
LUNG 1085 16 835 75 913 151 919
OTHER 8 2 104 7 85 8 49
PEOLC 31 3 157 4 49 8 49
PREV 40 1 52 3 37 3 18
SURV 99 2 104 9 110 12 73
SXQOL 364 9 470 33 402 69 420
Total 2932 49 2557 193 2351 363 2210

13-JUL-2020 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 503 12 626 38 463 73 444
CCD 1234 15 783 59 718 106 645
ERLYTX 173 0 0 3 37 8 49
GI 283 3 157 12 146 14 85
GU 725 16 835 61 743 127 773
LEUK 156 5 261 9 110 16 97
LUNG 1336 22 1148 99 1205 187 1138
LYMPH 223 5 261 25 304 54 329
MELAN 195 1 52 10 122 23 140
MMYEL 179 4 209 19 231 32 195
OTHER 32 3 157 11 134 15 91
PEOLC 31 3 157 4 49 8 49
PREV 40 1 52 3 37 3 18
SURV 99 2 104 9 110 12 73
SXQOL 375 10 522 35 426 72 438
Total 5584 102 5324 397 4835 750 4564

13-JUL-2020 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 262 7 365 20 244 35 213
ERLYTX 111 0 0 3 37 5 30
GI 158 1 52 8 97 10 61
GU 527 13 678 42 511 91 554
LEUK 148 5 261 9 110 15 91
LUNG 168 2 104 11 134 14 85
LYMPH 125 3 157 16 195 29 177
MELAN 133 1 52 8 97 18 110
MMYEL 120 2 104 11 134 19 116
OTHER 24 1 52 4 49 7 43
SXQOL 11 1 52 2 24 3 18
Total 1787 36 1877 134 1632 246 1498

13-JUL-2020 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 54 1 52 3 37 6 37
CCD 1051 14 730 57 694 103 627
GU 17 0 0 0 0 0 0
LUNG 601 7 365 32 390 76 463
OTHER 6 0 0 5 61 6 37
PEOLC 22 2 104 2 24 6 37
PREV 28 1 52 2 24 2 12
SURV 77 1 52 7 85 10 61
SXQOL 348 6 313 26 317 59 359
Total 2204 32 1668 134 1632 268 1633

13-JUL-2020 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 332 4 209 21 256 46 280
CCD 1071 15 783 57 694 104 633
ERLYTX 111 0 0 3 37 5 30
GI 183 1 52 9 110 13 79
GU 548 14 730 43 524 91 554
LEUK 154 5 261 10 122 17 103
LUNG 769 9 470 43 524 90 548
LYMPH 125 3 157 16 195 29 177
MELAN 133 1 52 8 97 18 110
MMYEL 120 2 104 11 134 19 116
OTHER 30 1 52 8 97 13 79
PEOLC 30 1 52 6 73 11 67
PREV 28 1 52 2 24 2 12
SURV 79 3 157 11 134 14 85
SXQOL 359 7 365 28 341 62 377
Total 4072 67 3496 276 3362 534 3250

13-JUL-2020 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 357 11 574 33 402 59 359
ERLYTX 156 0 0 2 24 7 43
GI 239 2 104 7 85 8 49
GU 558 12 626 51 621 108 657
LEUK 31 1 52 1 12 2 12
LUNG 211 6 313 23 280 34 207
LYMPH 169 4 209 19 231 40 244
MELAN 176 0 0 9 110 21 128
MMYEL 172 4 209 18 219 31 189
Total 2069 40 2087 163 1984 310 1888

13-JUL-2020 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

The REPORT Procedure

Detailed and/or summarized report

Table 1

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1784 35 1826 147 1790 270 1644
AFFIL 228 4 209 14 170 30 183
CCOP/NCORP 1979 29 1513 107 1303 214 1303
Non-SWOG 1591 32 1670 127 1546 234 1424
Total 5582 100 5218 395 4809 748 4554

13-JUL-2020 6:10

STUDIES OPENED THIS MONTH

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LUNG S1933 NSCLC, Stg II-III, RT + Atezo 2 Y 15-JUN-20
LUNG S1933 NSCLC, Stg II-III, RT + Atezo 1 Y 15-JUN-20
LUNG S1929 ESCLC, SLFN11+, Atezolizumab Talazoparib 2 Y 15-JUN-20
LUNG S1929 ESCLC, SLFN11+, Atezolizumab Talazoparib 1 Y 15-JUN-20

13-JUL-2020 6:10

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

The REPORT Procedure

Detailed and/or summarized report

Table 1

ADMIN STUDYID STNAME REGTYPE Registrations
LUNG LUNGMAP NSCLC, Adv, Master 2 16
LUNG LUNGMAP NSCLC, Adv, Master 1 16
CCD EA1151 CCD, Tomosynthesis Mammographic Screening 1 14
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 2 9
SXQOL S1714 CIPN Risk Prediction Cohort Study, Taxanes 1 9
GU S1602 Blad, HG NMIBC, TICE/Tokyo/Prime+Tokyo BCG 1 8
LEUK EA9161 CLL, untreated, IOV vs IO in younger pts 1 4
BREAST S1418 Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 4
SURV S1501 Surv, Breast Stg IV, Card Tox w/ Carvedilol 1 4
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 1 4
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 2 4
GU A031501 Bladder, MIBC/Loc Adv, Adjv Pembro vs Obs 0 3
LEUK EA9161 CLL, untreated, IOV vs IO in younger pts 0 3
LUNG LUNGMAP NSCLC, Adv, Master 0 3
OTHER NCICOVID NCI COVID-19 in Cancer Patients Study 0 3
LUNG S1800A Non-Match: Ramu + Pembro vs SoC 1 3
GU S1806 Blad, MIBC, ChemoRT +/- Atezolizumab 1 3
PEOLC S1820 Rectal, Diet modification to manage GI sx 2 3
LYMPH S1826 HD, Adv, Age 12+, N+AVD vs BV+AVD 1 3